Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
09/26/20185:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/25/20184:05PMPR Newswire (US)AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences in OctoberNASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/11/20187:00AMPR Newswire (US)AcelRx Announces Date of FDA Advisory Committee Meeting for DSUVIA™NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/05/20186:14AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/05/20186:10AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/05/20186:10AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/05/20186:10AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/23/20184:05PMPR Newswire (US)AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in SeptemberNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/20/20187:00AMPR Newswire (US)AcelRx Pharmaceuticals to Present at the 2018 Military Health System Research SymposiumNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/08/20184:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/08/20187:00AMPR Newswire (US)AcelRx Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/07/20184:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/06/20185:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/06/20185:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/02/20185:21PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/02/20184:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/02/20184:01PMPR Newswire (US)AcelRx Pharmaceuticals Reports Second Quarter 2018 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/19/20188:33AMPR Newswire (US)AcelRx to announce second quarter 2018 results and provide a corporate update on Thursday, August 2nd, 2018NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/13/20184:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/13/20184:04PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/12/20189:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common StockNASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/11/20184:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/11/20184:17PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/11/20184:07PMPR Newswire (US)AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common StockNASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/02/20186:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/27/20187:00AMPR Newswire (US)AcelRx receives European Commission approval for DZUVEO™NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/15/20186:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/14/20186:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/14/20186:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/14/20186:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX